In the last 12 months, insiders at Sensei Biotherapeutics, Inc. ($SNSE) filed 164 transactions with the SEC: 29 open-market purchases totaling $1,345,685 and 43 sales totaling $6,716,807. Net insider sentiment: net selling.
Sensei Biotherapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Apeiron Investment Group Ltd. (TenPercentOwner) — 4 transactions totaling $5,441,363
- Peyer James (Not found) — 13 transactions totaling $2,289,793
- Cambrian BioPharma Inc (Not found) — 13 transactions totaling $2,289,793
- MILLENNIUM MANAGEMENT LLC (TenPercentOwner) — 51 transactions totaling $2,046,174
- Celebi John (President and CEO) — 8 transactions totaling $31,163
View all SEC Filings for Sensei Biotherapeutics, Inc. (SNSE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 616 | $24.69 | 146,657.0000 | 1,261,290 | 0.42% | 0.05% |
| April 2, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 1265 | $31.75 | 144,974.0000 | 1,261,290 | 0.87% | 0.10% |
| April 2, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 3099 | $30.86 | 144,974.0000 | 1,261,290 | 2.09% | 0.25% |
| April 2, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 701 | $35.55 | 144,974.0000 | 1,261,290 | 0.49% | 0.06% |
| April 2, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1276 | $34.75 | 144,974.0000 | 1,261,290 | 0.89% | 0.10% |
| April 2, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 26 | $33.47 | 144,974.0000 | 1,261,290 | 0.02% | 0.00% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 411 | $32.60 | 146,657.0000 | 1,261,290 | 0.28% | 0.03% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1957 | $31.45 | 146,657.0000 | 1,261,290 | 1.35% | 0.16% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 186 | $30.48 | 146,657.0000 | 1,261,290 | 0.13% | 0.01% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 17 | $27.78 | 146,657.0000 | 1,261,290 | 0.01% | 0.00% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1048 | $26.73 | 146,657.0000 | 1,261,290 | 0.72% | 0.08% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1770 | $25.32 | 146,657.0000 | 1,261,290 | 1.22% | 0.14% |
| April 7, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 1108 | $33.38 | 133,986.0000 | 1,261,290 | 0.82% | 0.09% |
| April 2, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 1794 | $32.60 | 144,974.0000 | 1,261,290 | 1.22% | 0.14% |
| April 2, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 374 | $33.35 | 144,974.0000 | 1,261,290 | 0.26% | 0.03% |
| April 2, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 1134 | $34.80 | 144,974.0000 | 1,261,290 | 0.78% | 0.09% |
| April 6, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1104 | $31.02 | 141,029.0000 | 1,261,290 | 0.79% | 0.09% |
| April 6, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 1214 | $31.02 | 141,029.0000 | 1,261,290 | 0.85% | 0.10% |
| April 6, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 45 | $31.96 | 141,029.0000 | 1,261,290 | 0.03% | 0.00% |
| April 7, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1108 | $33.38 | 133,986.0000 | 1,261,290 | 0.83% | 0.09% |
| April 7, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 2115 | $28.94 | 133,986.0000 | 1,261,290 | 1.55% | 0.17% |
| April 7, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 205 | $29.71 | 133,986.0000 | 1,261,290 | 0.15% | 0.02% |
| April 7, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 4423 | $31.38 | 133,986.0000 | 1,261,290 | 3.20% | 0.35% |
| April 7, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 300 | $32.25 | 133,986.0000 | 1,261,290 | 0.22% | 0.02% |
| March 30, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 370 | $27.68 | 145,678.0000 | 1,261,290 | 0.25% | 0.03% |
| March 30, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 518 | $25.85 | 145,678.0000 | 1,261,290 | 0.35% | 0.04% |
| March 30, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 370 | $27.68 | 145,678.0000 | 1,261,290 | 0.25% | 0.03% |
| March 30, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1176 | $26.70 | 145,678.0000 | 1,261,290 | 0.81% | 0.09% |
| March 30, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 4995 | $25.99 | 145,678.0000 | 1,261,290 | 3.55% | 0.40% |
| March 30, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 2992 | $25.08 | 145,678.0000 | 1,261,290 | 2.10% | 0.24% |
| March 27, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 36 | $27.37 | 142,360.0000 | 1,261,290 | 0.03% | 0.00% |
| March 27, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 469 | $26.77 | 142,360.0000 | 1,261,290 | 0.33% | 0.04% |
| March 27, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 294 | $28.13 | 142,360.0000 | 1,261,290 | 0.21% | 0.02% |
| March 27, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 4384 | $27.28 | 142,360.0000 | 1,261,290 | 3.18% | 0.35% |
| March 27, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 10643 | $26.29 | 142,360.0000 | 1,261,290 | 8.08% | 0.84% |
| March 26, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 1274 | $28.69 | 131,370.0000 | 1,261,290 | 0.96% | 0.10% |
| March 26, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 583 | $26.88 | 131,370.0000 | 1,261,290 | 0.44% | 0.05% |
| March 26, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1025 | $29.98 | 131,370.0000 | 1,261,290 | 0.79% | 0.08% |
| March 26, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 2601 | $28.85 | 131,370.0000 | 1,261,290 | 2.02% | 0.21% |
| March 26, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1327 | $27.95 | 131,370.0000 | 1,261,290 | 1.02% | 0.11% |
| March 26, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 778 | $27.23 | 131,370.0000 | 1,261,290 | 0.60% | 0.06% |
| April 1, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 46 | $34.75 | 147,731.0000 | 1,261,290 | 0.03% | 0.00% |
| April 1, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 1104 | $31.52 | 147,731.0000 | 1,261,290 | 0.74% | 0.09% |
| April 1, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 3401 | $35.46 | 147,731.0000 | 1,261,290 | 2.36% | 0.27% |
| April 1, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1613 | $34.59 | 147,731.0000 | 1,261,290 | 1.10% | 0.13% |
| April 1, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | P | Common Stock | 1161 | $31.53 | 147,731.0000 | 1,261,290 | 0.79% | 0.09% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 87 | $31.52 | 146,657.0000 | 1,261,290 | 0.06% | 0.01% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 5 | $28.41 | 146,657.0000 | 1,261,290 | 0.00% | 0.00% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 57 | $27.11 | 146,657.0000 | 1,261,290 | 0.04% | 0.00% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 1251 | $25.17 | 146,657.0000 | 1,261,290 | 0.85% | 0.10% |
| March 31, 2026 | MILLENNIUM MANAGEMENT LLC | TenPercentOwner | S | Common Stock | 191 | $24.28 | 146,657.0000 | 1,261,290 | 0.13% | 0.02% |
| April 10, 2026 | Donenberg Phillip B. | Not found | A | Stock Option (right to buy) | 23100 | $0.00 | 23,100.0000 | 1,261,290 | 9999.99% | 1.83% |
| April 10, 2026 | Craver Josiah | PFO & PAO | A | Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 1,261,290 | 9999.99% | 6.34% |
| Feb. 19, 2026 | Parikh Anand Kiran | Chief Operating Officer | A | Employee Stock Option (right to buy) | 1239305 | $0.00 | 1,239,305.0000 | 1,261,290 | 9999.99% | 98.26% |
| Feb. 17, 2026 | Parikh Anand Kiran | Chief Operating Officer | A | Employee Stock Option (right to buy) | 56673 | $0.00 | 56,673.0000 | 1,261,290 | 9999.99% | 4.49% |
| Feb. 17, 2026 | Parikh Anand Kiran | Chief Operating Officer | A | Employee Stock Option (right to buy) | 92533 | $0.00 | 92,533.0000 | 1,261,290 | 9999.99% | 7.34% |
| Feb. 17, 2026 | Parikh Anand Kiran | Chief Operating Officer | A | Series B Preferred Stock | 809822 | $0.00 | 809,822.0000 | 1,261,290 | 9999.99% | 64.21% |
| Feb. 13, 2026 | Donenberg Phillip B. | Not found | A | Stock Option (right to buy) | 1900 | $0.00 | 1,900.0000 | 1,261,290 | 9999.99% | 0.15% |
| Dec. 9, 2025 | Cambrian BioPharma Inc | Not found | M | Stock Option (Right to Buy) | 395 | $0.00 | 0.0000 | 1,261,290 | 100.00% | 0.03% |
| Dec. 9, 2025 | Cambrian BioPharma Inc | Not found | S | Common Stock | 3105 | $8.59 | 158,254.0000 | 1,261,290 | 1.92% | 0.25% |
| Dec. 9, 2025 | Cambrian BioPharma Inc | Not found | S | Common Stock | 2666 | $7.95 | 155,588.0000 | 1,261,290 | 1.68% | 0.21% |
| Dec. 9, 2025 | Cambrian BioPharma Inc | Not found | M | Common Stock | 395 | $6.40 | 155,983.0000 | 1,261,290 | 0.25% | 0.03% |
| Dec. 9, 2025 | Cambrian BioPharma Inc | Not found | S | Common Stock | 395 | $8.04 | 155,588.0000 | 1,261,290 | 0.25% | 0.03% |
| Dec. 9, 2025 | Cambrian BioPharma Inc | Not found | S | Common Stock | 446 | $7.92 | 155,142.0000 | 1,261,290 | 0.29% | 0.04% |
| Dec. 8, 2025 | Peyer James | Not found | S | Common Stock | 3105 | $8.59 | 158,254.0000 | 1,261,290 | 1.92% | 0.25% |
| Dec. 9, 2025 | Peyer James | Not found | S | Common Stock | 2666 | $7.95 | 155,588.0000 | 1,261,290 | 1.68% | 0.21% |
| Dec. 9, 2025 | Peyer James | Not found | M | Common Stock | 395 | $6.40 | 155,983.0000 | 1,261,290 | 0.25% | 0.03% |
| Dec. 9, 2025 | Peyer James | Not found | S | Common Stock | 395 | $8.04 | 155,588.0000 | 1,261,290 | 0.25% | 0.03% |
| Dec. 9, 2025 | Peyer James | Not found | S | Common Stock | 446 | $7.92 | 155,142.0000 | 1,261,290 | 0.29% | 0.04% |
| Dec. 9, 2025 | Peyer James | Not found | M | Stock Option (Right to Buy) | 395 | $0.00 | 0.0000 | 1,261,290 | 100.00% | 0.03% |
| Dec. 5, 2025 | Cambrian BioPharma Inc | Not found | S | Common Stock | 14508 | $11.40 | 163,146.0000 | 1,261,290 | 8.17% | 1.15% |
| Dec. 5, 2025 | Cambrian BioPharma Inc | Not found | S | Common Stock | 1745 | $12.29 | 161,401.0000 | 1,261,290 | 1.07% | 0.14% |
| Dec. 5, 2025 | Cambrian BioPharma Inc | Not found | S | Common Stock | 42 | $13.16 | 161,359.0000 | 1,261,290 | 0.03% | 0.00% |
| Dec. 4, 2025 | Peyer James | Not found | S | Common Stock | 5000 | $9.06 | 177,654.0000 | 1,261,290 | 2.74% | 0.40% |
| Dec. 5, 2025 | Peyer James | Not found | S | Common Stock | 14508 | $11.40 | 163,146.0000 | 1,261,290 | 8.17% | 1.15% |
| Dec. 5, 2025 | Peyer James | Not found | S | Common Stock | 1745 | $12.29 | 161,401.0000 | 1,261,290 | 1.07% | 0.14% |
| Dec. 5, 2025 | Peyer James | Not found | S | Common Stock | 42 | $13.16 | 161,359.0000 | 1,261,290 | 0.03% | 0.00% |
| Dec. 4, 2025 | Cambrian BioPharma Inc | Not found | S | Common Stock | 5000 | $9.06 | 177,654.0000 | 1,261,290 | 2.74% | 0.40% |
| May 21, 2025 | RINGO WILLIAM R | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 25,117,238 | 9999.99% | 0.08% |
| May 21, 2025 | Holmen Bob | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 25,117,238 | 9999.99% | 0.08% |
| May 21, 2025 | Humer Kristian | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 25,117,238 | 9999.99% | 0.08% |
| May 21, 2025 | Peyer James | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 25,117,238 | 9999.99% | 0.08% |
| May 21, 2025 | RICKS THOMAS G | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 25,117,238 | 9999.99% | 0.08% |
| May 21, 2025 | Cambrian BioPharma Inc | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 25,117,238 | 9999.99% | 0.08% |
| Feb. 19, 2025 | Celebi John | PRESIDENT AND CEO | F | Common Stock | 5558 | $0.48 | 105,862.0000 | 25,117,238 | 4.99% | 0.02% |
| Feb. 19, 2025 | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 2276 | $0.48 | 59,794.0000 | 25,117,238 | 3.67% | 0.01% |
| Feb. 14, 2025 | Krebs Stephanie | Chief Business Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 25,117,238 | 9999.99% | 0.48% |
| Feb. 14, 2025 | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 25,117,238 | 9999.99% | 0.44% |
| Feb. 14, 2025 | Celebi John | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 360000 | $0.00 | 360,000.0000 | 25,117,238 | 9999.99% | 1.43% |
| Feb. 14, 2025 | Craver Josiah | Principal Financial Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 25,117,238 | 9999.99% | 0.20% |
| Dec. 20, 2024 | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 1,257,299 | 9999.99% | 7.95% |
| Dec. 20, 2024 | Celebi John | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 355000 | $0.00 | 355,000.0000 | 1,257,299 | 9999.99% | 28.24% |
| Dec. 20, 2024 | Craver Josiah | Principal Financial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 1,257,299 | 9999.99% | 7.95% |
| Dec. 20, 2024 | Krebs Stephanie | Chief Business Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 1,257,299 | 9999.99% | 9.54% |
| June 11, 2024 | Humer Kristian | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| June 11, 2024 | Cambrian BioPharma Inc | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| June 11, 2024 | Peyer James | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| June 11, 2024 | Holmen Bob | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| June 11, 2024 | English Jessie | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| June 11, 2024 | RINGO WILLIAM R | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| June 11, 2024 | RICKS THOMAS G | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| June 11, 2024 | Vojta Deneen | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| Feb. 15, 2024 | Colgan Erin | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 94128 | $0.00 | 94,128.0000 | 27,952,857 | 9999.99% | 0.34% |
| Feb. 15, 2024 | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 2843 | $0.79 | 56,070.0000 | 27,952,857 | 4.83% | 0.01% |
| Feb. 15, 2024 | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 27,952,857 | 9999.99% | 0.45% |
| Feb. 15, 2024 | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 90102 | $0.00 | 90,102.0000 | 27,952,857 | 9999.99% | 0.32% |
| Feb. 15, 2024 | Celebi John | PRESIDENT AND CEO | F | Common Stock | 5891 | $0.79 | 105,420.0000 | 27,952,857 | 5.29% | 0.02% |
| Feb. 15, 2024 | Celebi John | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 315000 | $0.00 | 315,000.0000 | 27,952,857 | 9999.99% | 1.13% |
| Feb. 15, 2024 | Celebi John | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 165889 | $0.00 | 165,889.0000 | 27,952,857 | 9999.99% | 0.59% |
| Feb. 15, 2024 | Colgan Erin | CHIEF FINANCIAL OFFICER | F | Common Stock | 3627 | $0.79 | 67,462.0000 | 27,952,857 | 5.10% | 0.01% |
| Feb. 15, 2024 | Colgan Erin | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 27,952,857 | 9999.99% | 0.45% |
| Nov. 1, 2023 | Krebs Stephanie | Chief Business Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2023 | Celebi John | President and CEO | P | Common Stock | 500 | $0.85 | 111,311.0000 | 0 | 0.45% | 0.00% |
| Feb. 15, 2023 | Celebi John | President and CEO | F | Common Stock | 20492 | $1.50 | 110,811.0000 | 0 | 15.61% | 0.00% |
| Feb. 15, 2023 | Gallagher Patrick Stephen | Chief Business Officer | F | Common Stock | 9383 | $1.50 | 34,130.0000 | 0 | 21.56% | 0.00% |
| Feb. 15, 2023 | van der Horst Edward | Chief Scientific Officer | F | Common Stock | 9525 | $1.50 | 52,913.0000 | 0 | 15.26% | 0.00% |
| Feb. 15, 2023 | Colgan Erin | Chief Financial Officer | F | Common Stock | 10943 | $1.50 | 68,089.0000 | 0 | 13.85% | 0.00% |
| July 31, 2023 | Cambrian BioPharma Inc | Not found | D | Common Stock | 1587302 | $1.26 | 3,653,120.0000 | 0 | 30.29% | 0.00% |
| July 31, 2023 | Peyer James | Not found | D | Common Stock | 1587302 | $1.26 | 3,653,120.0000 | 0 | 30.29% | 0.00% |
| July 10, 2023 | Humer Kristian | Director | A | Common Stock | 4466 | $0.00 | 8,932.0000 | 0 | 100.00% | 0.00% |
| July 10, 2023 | Cambrian BioPharma Inc | TenPercentOwner | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | Cambrian BioPharma Inc | TenPercentOwner | A | Common Stock | 4466 | $0.00 | 5,240,422.0000 | 0 | 0.09% | 0.00% |
| July 10, 2023 | Peyer James | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | Peyer James | Director | A | Common Stock | 4466 | $0.00 | 5,240,422.0000 | 0 | 0.09% | 0.00% |
| July 10, 2023 | Holmen Bob | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | Holmen Bob | Director | A | Common Stock | 4466 | $0.00 | 25,598.0000 | 0 | 21.13% | 0.00% |
| July 10, 2023 | Vojta Deneen | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | Vojta Deneen | Director | A | Common Stock | 4466 | $0.00 | 8,932.0000 | 0 | 100.00% | 0.00% |
| July 10, 2023 | English Jessie | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | English Jessie | Director | A | Common Stock | 4466 | $0.00 | 8,932.0000 | 0 | 100.00% | 0.00% |
| July 10, 2023 | Humer Kristian | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | Broder Samuel | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | Broder Samuel | Director | A | Common Stock | 4466 | $0.00 | 8,932.0000 | 0 | 100.00% | 0.00% |
| July 10, 2023 | RICKS THOMAS G | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | RICKS THOMAS G | Director | A | Common Stock | 4466 | $0.00 | 343,863.0000 | 0 | 1.32% | 0.00% |
| July 10, 2023 | RINGO WILLIAM R | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | RINGO WILLIAM R | Director | A | Common Stock | 4466 | $0.00 | 23,399.0000 | 0 | 23.59% | 0.00% |
| June 1, 2023 | Apeiron Investment Group Ltd. | TenPercentOwner | S | Common Stock | 955738 | $1.58 | 0.0000 | 0 | 100.00% | 0.00% |
| June 1, 2023 | Apeiron Investment Group Ltd. | TenPercentOwner | S | Common Stock | 2485923 | $1.58 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 15, 2023 | Gallagher Patrick Stephen | Chief Business Officer | A | Common Stock | 14200 | $0.00 | 43,513.0000 | 0 | 48.44% | 0.00% |
| Feb. 15, 2023 | Gallagher Patrick Stephen | Chief Business Officer | A | Common Stock | 29313 | $0.00 | 29,313.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Celebi John | President and CEO | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Celebi John | President and CEO | A | Common Stock | 21300 | $0.00 | 131,303.0000 | 0 | 19.36% | 0.00% |
| Feb. 15, 2023 | Celebi John | President and CEO | A | Common Stock | 51893 | $0.00 | 110,003.0000 | 0 | 89.30% | 0.00% |
| Feb. 15, 2023 | Colgan Erin | Chief Financial Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Colgan Erin | Chief Financial Officer | A | Common Stock | 30046 | $0.00 | 57,732.0000 | 0 | 108.52% | 0.00% |
| Feb. 15, 2023 | Colgan Erin | Chief Financial Officer | A | Common Stock | 21300 | $0.00 | 79,032.0000 | 0 | 36.89% | 0.00% |
| Feb. 15, 2023 | Gallagher Patrick Stephen | Chief Business Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2022 | Cambrian BioPharma Inc | TenPercentOwner | A | Stock Option (right to buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2022 | Cambrian BioPharma Inc | TenPercentOwner | A | Restricted Stock Unit Grant | 4466 | $0.00 | 5,235,956.0000 | 0 | 0.09% | 0.00% |
| Feb. 23, 2023 | Apeiron Investment Group Ltd. | TenPercentOwner | P | Common Stock | 1100 | $1.60 | 3,441,661.0000 | 0 | 0.03% | 0.00% |
| Feb. 23, 2023 | Apeiron Investment Group Ltd. | TenPercentOwner | P | Common Stock | 1100 | $1.62 | 3,440,561.0000 | 0 | 0.03% | 0.00% |
| Feb. 15, 2023 | Gallagher Patrick Stephen | Chief Business Officer | A | Common Stock | 14200 | $0.00 | 43,515.0000 | 0 | 48.44% | 0.00% |
| Feb. 15, 2023 | Gallagher Patrick Stephen | Chief Business Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Colgan Erin | Chief Financial Officer | A | Common Stock | 30046 | $0.00 | 51,732.0000 | 0 | 138.55% | 0.00% |
| Feb. 15, 2023 | Colgan Erin | Chief Financial Officer | A | Common Stock | 21300 | $0.00 | 73,032.0000 | 0 | 41.17% | 0.00% |
| Feb. 15, 2023 | Colgan Erin | Chief Financial Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Celebi John | President and CEO | A | Common Stock | 51893 | $0.00 | 106,007.0000 | 0 | 95.90% | 0.00% |
| Feb. 15, 2023 | Gallagher Patrick Stephen | Chief Business Officer | A | Common Stock | 29313 | $0.00 | 29,313.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Celebi John | President and CEO | A | Common Stock | 21300 | $0.00 | 127,307.0000 | 0 | 20.09% | 0.00% |
| Feb. 15, 2023 | Celebi John | President and CEO | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | van der Horst Edward | Chief Scientific Officer | A | Common Stock | 17700 | $0.00 | 62,438.0000 | 0 | 39.56% | 0.00% |
| Feb. 15, 2023 | van der Horst Edward | Chief Scientific Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | van der Horst Edward | Chief Scientific Officer | A | Common Stock | 23565 | $0.00 | 44,738.0000 | 0 | 111.30% | 0.00% |